Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6) Peptide
SSX6
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all SSX6 products
- SSX6 (Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- IPKIMPEKPA EEGSDSKGVP EASGPQNDGK KLCPPGKASS SEKIHERSGP
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SSX6 antibody,
Alternative Names: SSX6 control peptide, SSX6 antibody Blocking Peptide, Anti-SSX6 Blocking Peptide, synovial sarcoma, X breakpoint 6 Blocking Peptide, dJ54B20.1 Blocking Peptide, SSX6, SSX-6, SSX 6, SSX-6 Blocking Peptide, SSX 6 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- SSX6 (Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6))
- Synonyms
- SSXP2 Peptide, dJ54B20.1 Peptide, psiSSX2 Peptide, SSX family member 6, pseudogene Peptide, SSX6 Peptide
- Background
- SSX6 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy.
- Molecular Weight
- 22 kDa
-
You are here:
